Evaluating novel approaches for estimating awake and sleep blood pressure: design of the Better BP Study - a randomised, crossover trial.
Evaluating novel approaches for estimating awake and sleep blood pressure: design of the Better BP Study - a randomised, crossover trial.
复制标题
评估评估清醒和睡眠血压的新方法:更好的BP研究设计-一项随机交叉试验。
DOI:
10.1136/bmjopen-2021-058140
复制
发表时间:
2022-06-06
期刊:
影响因子:
2.9
通讯作者:
Shimbo, Daichi
中科院分区:
文献类型:
--
作者:
Cepeda, Maria;Hubbard, Demetria;Oparil, Suzanne;Schwartz, Joseph E.;Jaeger, Byron C.;Hardy, Shakia T.;Medina, Julia;Chen, Ligong;Muntner, Paul;Shimbo, Daichi
For many people, blood pressure (BP) levels differ when measured in a medical office versus outside of the office setting. Out-of-office BP has a stronger association with cardiovascular disease (CVD) events compared with BP measured in the office. Many BP guidelines recommend measuring BP outside of the office to confirm the levels obtained in the office. Ambulatory BP monitoring (ABPM) can assess out-of-office BP but is not available in many US practices and some individuals find it uncomfortable. The aims of the Better BP Study are to (1) test if unattended office BP is closer to awake BP on ABPM compared with attended office BP, (2) assess if sleep BP assessed by home BP monitoring (HBPM) agrees with sleep BP from a full night of ABPM and (3) compare the strengths of associations of unattended versus attended office BP, unattended office BP versus awake BP on ABPM and sleep BP on HBPM versus ABPM with markers of end-organ damage. We are recruiting 630 adults not taking antihypertensive medication in Birmingham, Alabama, and New York, New York. Participants are having their office BP measured with (attended) and without (unattended) a technician present, in random order, using an automated oscillometric office BP device during each of two visits within one week. Following these visits, participants complete 24 hours of ABPM and one night of HBPM, in random order. Psychosocial factors, anthropometrics, left ventricular mass index and albumin-to-creatinine ratio are also being assessed. This study was approved by the University of Alabama at Birmingham and the Columbia University Medical Center Institutional Review Boards. The study results will be disseminated at scientific conferences and published in peer-reviewed journals. NCT04307004.
登录
查看更多内容
影响因子:
2.7
作者:
通讯作者:
--
影响因子:
24
作者:
Schwartz JE;Muntner P;Kronish IM;Burg MM;Pickering TG;Bigger JT;Shimbo D
通讯作者:
Shimbo D
影响因子:
39.2
作者:
Shimbo D;Abdalla M;Falzon L;Townsend RR;Muntner P
通讯作者:
Muntner P
影响因子:
4.9
作者:
Myers, Martin G.;Valdivieso, Miguel;Kiss, Alexander
通讯作者:
Kiss, Alexander
DOI:
10.1161/hypertensionaha.116.07553
发表时间:
2016-08
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Booth JN 3rd;Diaz KM;Seals SR;Sims M;Ravenell J;Muntner P;Shimbo D
通讯作者:
Shimbo D